ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732837 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732837; 2) Community: the network communities that were significantly associated with the response to NSC 732837; 3) Molecule: the relationships between components within communities and NSC 732837; 4) MDR: the compounds that were significantly associated with the NSC 732837.

NSC Compound Enrichment Correlation
NSC 261045 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, hydrochloride 0.0176693828663435 0.015813149
NSC 369327 ELSAMICIN 0.0176693828663435 0.28603707
NSC 646106 Null 0.0176693828663435 0.098400643
NSC 696134 Null 0.0176693828663435 0.11653003
NSC 721045 Null 0.0176693828663435 -0.0095262098
NSC 757569 Null 0.0176693828663438 0.1595092
NSC 750746 (E)-1-(3,4-dimethoxyphenyl)-3-(2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one 0.0181211508101517 0.5153039
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.0181211508101519 0.40392762
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0181211508101519 0.44123055
NSC 113951 6-Bromotoyocamycin 0.0181211508101519 0.53033432
Total:68  Current:19    [First] [Prev] [Next] [Last]